Inspire names Adrian Adams president and CEO
This article was originally published in Scrip
Executive Summary
Inspire Pharmaceuticals (US) has named Adrian Adams president and chief executive officer, and has also elected him to its board of directors. Mr Adams recently stepped down as Sepracor's president and CEO in the wake of the company's recent acquisition by Japan's Dainippon Sumitomo Pharma (scripnews.com, February 19th, 2010).